Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data

por Detke, Holland C, Zhao, Fangyi, Witte, Michael M
Publicado 2012

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

por Zhao, Fangyi, Cheng, Ziqian, Piao, Jingjing, Cui, Ranji, Li, Bingjin
Publicado 2022

Brain–immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders

por Zhao, Fangyi, Li, Bingjin, Yang, Wei, Ge, Tongtong, Cui, Ranji
Publicado 2022

Efficacy and safety of ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis: Subgroup analysis of a placebo‐controlled, phase 3 study (UNCOVER‐1)...

por Imafuku, Shinichi, Torisu‐Itakura, Hitoe, Nishikawa, Atsushi, Zhao, Fangyi, Cameron, Gregory S.
Publicado 2017

Rasd2 Mediates Acute Fasting-Induced Antidepressant-Like Effects via Dopamine D2 Receptor Activation in Ovariectomized Mice

por Cheng, Ziqian, Zhang, Chaohe, Zhao, Fangyi, Piao, Jingjing, Cui, Ranji, Li, Bingjin
Publicado 2023

Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines

por Fu, Xiying, Wang, Yicun, Zhao, Fangyi, Cui, Ranji, Xie, Wei, Liu, Qianqian, Yang, Wei
Publicado 2023

Role of Leptin in Mood Disorder and Neurodegenerative Disease

por Zou, Xiaohan, Zhong, Lili, Zhu, Cuilin, Zhao, Haisheng, Zhao, Fangyi, Cui, Ranji, Gao, Shuohui, Li, Bingjin
Publicado 2019

Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes

por Xu, Wenbo, Yao, Xiaoxiao, Zhao, Fangyi, Zhao, Haisheng, Cheng, Ziqian, Yang, Wei, Cui, Ranji, Xu, Songbai, Li, Bingjin
Publicado 2020

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases

por Detke, Holland C, McDonnell, David P, Brunner, Elizabeth, Zhao, Fangyi, Sorsaburu, Sebastian, Stefaniak, Victoria J, Corya, Sara A
Publicado 2010

Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience

por Callis Duffin, Kristina, Bukhalo, Michael, Bobonich, Margaret A, Shrom, David, Zhao, Fangyi, Kershner, James R, Gill, Anne, Pangallo, Beth, Shuler, Catherine L, Bagel, Jerry
Publicado 2016

Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism

por Li, Ming, Yao, Xiaoxiao, Sun, Lihua, Zhao, Lihong, Xu, Wenbo, Zhao, Haisheng, Zhao, Fangyi, Zou, Xiaohan, Cheng, Ziqian, Li, Bingjin, Yang, Wei, Cui, Ranji
Publicado 2020

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

por Ascher-Svanum, Haya, Zhao, Fangyi, Detke, Holland C, Nyhuis, Allen W, Lawson, Anthony H, Stauffer, Virginia L, Montgomery, William, Witte, Michael M, McDonnell, David P
Publicado 2011

Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

por Nisenbaum, Laura K., Downing, AnnCatherine M., Zhao, Fangyi, Millen, Brian A., Munsie, Leanne, Kinon, Bruce J., Adams, David H., Gomez, Juan Carlos, Penny, Michelle Ann
Publicado 2016

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

por Downing, AnnCatherine M, Kinon, Bruce J, Millen, Brian A, Zhang, Lu, Liu, Lin, Morozova, Margarita A, Brenner, Ronald, Rayle, Tami Jo, Nisenbaum, Laura, Zhao, Fangyi, Gomez, Juan Carlos
Publicado 2014

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis

por Mease, Philip, Walsh, Jessica A., Baraliakos, Xenofon, Inman, Robert, de Vlam, Kurt, Wei, James Cheng-Chung, Hunter, Theresa, Gallo, Gaia, Sandoval, David, Zhao, Fangyi, Dong, Yan, Bolce, Rebecca, Marzo-Ortega, Helena
Publicado 2019

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials

por Stein Gold, Linda, Thaçi, Diamant, Thyssen, Jacob P., Gooderham, Melinda, Laquer, Vivian, Moore, Angela, Natalie, Chitra R., Zhao, Fangyi, Meskimen, Eric, Elmaraghy, Hany, Montmayeur, Sonia, Gallo, Gaia, Jimenez, Gemma, de Bruin-Weller, Marjolein
Publicado 2023

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial...

por Deodhar, Atul, Poddubnyy, Denis, Pacheco‐Tena, Cesar, Salvarani, Carlo, Lespessailles, Eric, Rahman, Proton, Järvinen, Pentti, Sanchez‐Burson, Juan, Gaffney, Karl, Lee, Eun Bong, Krishnan, Eswar, Santisteban, Silvia, Li, Xiaoqi, Zhao, Fangyi, Carlier, Hilde, Reveille, John D.
Publicado 2019

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and...

por Dougados, Maxime, Wei, James Cheng-Chung, Landewé, Robert, Sieper, Joachim, Baraliakos, Xenofon, Van den Bosch, Filip, Maksymowych, Walter P, Ermann, Joerg, Walsh, Jessica A, Tomita, Tetsuya, Deodhar, Atul, van der Heijde, Désirée, Li, Xiaoqi, Zhao, Fangyi, Bertram, Clinton C, Gallo, Gaia, Carlier, Hilde, Gensler, Lianne S
Publicado 2020